Proxy Votes Now

Home › Funds › T. Rowe Price › T. Rowe Price Global Impact Equity Fund

T. Rowe Price Global Impact Equity Fund (TGBLX) proxy voting record 2025-2026

Fund family: T. Rowe Price · Filed by T. Rowe Price International Funds, Inc. (CIK 313212) · SEC series S000070716

Share classes and tickers: TGBLX (C000224811), TGPEX (C000224810)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 834 with, 15 against, 1 abstentions (not counted as with management); 3 items carried no recommendation. Shareholder proposals: 4 FOR, 13 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with T. Rowe Price as a whole

The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsT. Rowe PriceItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)91.6%72593.7%208,710
Backed environmental and social shareholder proposals at US companiesn/a62.6%3,333

Where this fund voted differently from most T. Rowe Price funds

Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most T. Rowe Price funds on 34 items (4.3% of the 798 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Linde Plc2025-07-29Shareholder A shareholder proposal requesting an annual report regarding the alignment of the Company's direct and indirect lobbying activities with the Company's 2050 climate neutrality ambition.ForAGAINST — 30 of 30 T. Rowe Price fundsAgainst—
Intuitive Surgical, Inc.2026-04-30Election of Directors: Amy L. Ladd, M.D.AgainstFOR — 29 of 29 T. Rowe Price fundsAgainstElected, 99.5% support
Intuitive Surgical, Inc.2026-04-30Election of Directors: Craig H. Barratt, Ph.D.AgainstFOR — 29 of 29 T. Rowe Price fundsAgainstElected, 96.6% support
Intuitive Surgical, Inc.2026-04-30Election of Directors: Gary S. Guthart, Ph.D.AgainstFOR — 29 of 29 T. Rowe Price fundsAgainstElected, 97.4% support
Intuitive Surgical, Inc.2026-04-30Election of Directors: Jami Dover NachtsheimAgainstFOR — 29 of 29 T. Rowe Price fundsAgainstElected, 98.3% support
Intuitive Surgical, Inc.2026-04-30Election of Directors: Joseph C. BeeryAgainstFOR — 29 of 29 T. Rowe Price fundsAgainstElected, 98.7% support
Intuitive Surgical, Inc.2026-04-30Election of Directors: Keith R. Leonard, Jr.AgainstFOR — 29 of 29 T. Rowe Price fundsAgainstElected, 99.5% support
Intuitive Surgical, Inc.2026-04-30Election of Directors: Lewis ChewAgainstFOR — 29 of 29 T. Rowe Price fundsAgainstElected, 99.1% support
Intuitive Surgical, Inc.2026-04-30Election of Directors: Monica P. Reed, M.D.AgainstFOR — 29 of 29 T. Rowe Price fundsAgainstElected, 97.8% support
Intuitive Surgical, Inc.2026-04-30Election of Directors: Sreelakshmi KolliAgainstFOR — 29 of 29 T. Rowe Price fundsAgainstElected, 98.9% support
Monolithic Power Systems, Inc.2026-06-11Election of Directors: Jeff ZhouWithholdFOR — 29 of 29 T. Rowe Price fundsAgainstPassed (calculated), 94.0% support
Monolithic Power Systems, Inc.2026-06-11Election of Directors: Victor K. LeeWithholdFOR — 29 of 29 T. Rowe Price fundsAgainstPassed (calculated), 89.8% support
MercadoLibre, Inc.2026-06-09Election of Directors: Class I Nominees: Alejandro Nicolas AguzinWithholdFOR — 18 of 18 T. Rowe Price fundsAgainstPassed (calculated), 98.6% support
MercadoLibre, Inc.2026-06-09Election of Directors: Class I Nominees: Susan SegalWithholdFOR — 18 of 18 T. Rowe Price fundsAgainstPassed (calculated), 94.2% support
Orsted A/S2026-04-09Reelect Lene Skole (Chair) as DirectorAbstainFOR — 16 of 16 T. Rowe Price fundsAgainst—
Eli Lilly and Company2026-05-04Shareholder Shareholder proposal to prepare an annual lobbying report.ForAGAINST — 37 of 40 T. Rowe Price fundsAgainstNot approved, 14.9% support
Popular, Inc.2026-05-08Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Alejandro M. BallesterAgainstFOR — 14 of 14 T. Rowe Price fundsAgainstPassed (calculated), 96.0% support
Popular, Inc.2026-05-08Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Alejandro M. SanchezAgainstFOR — 14 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.9% support
Popular, Inc.2026-05-08Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Bertil E. ChappuisAgainstFOR — 14 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.7% support
Popular, Inc.2026-05-08Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Betty DeVitaAgainstFOR — 14 of 14 T. Rowe Price fundsAgainstPassed (calculated), 98.6% support
Popular, Inc.2026-05-08Elect eleven directors to the Board of Directors of the Corporation for a one-year term: C. Kim GoodwinAgainstFOR — 14 of 14 T. Rowe Price fundsAgainstPassed (calculated), 96.4% support
Popular, Inc.2026-05-08Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Carlos A. UnanueAgainstFOR — 14 of 14 T. Rowe Price fundsAgainstPassed (calculated), 96.5% support
Popular, Inc.2026-05-08Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Jose R. RodriguezAgainstFOR — 14 of 14 T. Rowe Price fundsAgainstPassed (calculated), 97.7% support
Popular, Inc.2026-05-08Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Maria Luisa Ferre RangelAgainstFOR — 14 of 14 T. Rowe Price fundsAgainstPassed (calculated), 94.4% support
Popular, Inc.2026-05-08Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Richard L. CarrionAgainstFOR — 14 of 14 T. Rowe Price fundsAgainstPassed (calculated), 96.7% support
Show all 34
Items 26 to 34.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Popular, Inc.2026-05-08Elect eleven directors to the Board of Directors of the Corporation for a one-year term: Robert CarradyAgainstFOR — 14 of 14 T. Rowe Price fundsAgainstPassed (calculated), 98.5% support
Badger Meter, Inc.2026-04-24Election of Directors: Glen E. TellockWithholdFOR — 5 of 5 T. Rowe Price fundsAgainstElected, 97.7% support
Badger Meter, Inc.2026-04-24Election of Directors: Henry F. BrooksWithholdFOR — 5 of 5 T. Rowe Price fundsAgainstElected, 99.6% support
Badger Meter, Inc.2026-04-24Election of Directors: James F. SternWithholdFOR — 5 of 5 T. Rowe Price fundsAgainstElected, 99.1% support
Badger Meter, Inc.2026-04-24Election of Directors: James W. McGillWithholdFOR — 5 of 5 T. Rowe Price fundsAgainstElected, 98.9% support
Badger Meter, Inc.2026-04-24Election of Directors: Melanie K. CookWithholdFOR — 5 of 5 T. Rowe Price fundsAgainstElected, 99.5% support
Badger Meter, Inc.2026-04-24Election of Directors: Tessa M. MyersWithholdFOR — 5 of 5 T. Rowe Price fundsAgainstElected, 99.5% support
Badger Meter, Inc.2026-04-24Election of Directors: Todd A. AdamsWithholdFOR — 5 of 5 T. Rowe Price fundsAgainstElected, 99.4% support
Badger Meter, Inc.2026-04-24Election of Directors: Xia LiuWithholdFOR — 5 of 5 T. Rowe Price fundsAgainstElected, 99.2% support

Download all 34 differences (CSV)

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections4550
Corporate Governance1097
Capital Structure900
Compensation780
Audit-related650
Say-on-Pay390
Other Social Issues84
Environment or Climate54
Other40
Extraordinary Transactions20

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Broadcom Inc.April 20, 2026$937,854100
Deere & CompanyFebruary 25, 2026$767,796153
Thermo Fisher Scientific Inc.May 20, 2026$745,036130
Danaher CorporationMay 5, 2026$643,618140
Gilead Sciences, Inc.April 30, 2026$620,381153
Natera, Inc.June 11, 2026$608,69380
Aflac IncorporatedMay 4, 2026$584,941141
Eli Lilly and CompanyMay 4, 2026$571,986102

Notable votes against management

MeetingCompanyProposalFundMgmt
February 25, 2026Deere & CompanyShareholder proposal on a report on the return on investment of emission reduction goals Shareholder proposalAgainstFor
February 25, 2026Deere & CompanyShareholder proposal on shareholder right to act by written consent Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
May 4, 2026Aflac IncorporatedIndependent Board Chairman Shareholder proposalAgainstFor
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalAgainstFor
May 4, 2026Eli Lilly and CompanyShareholder proposal to prepare an annual lobbying report. Shareholder proposalForAgainst
June 1, 2026UnitedHealth Group IncorporatedIf properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposalAgainstFor
April 16, 2026Synopsys, Inc.To vote on a stockholder proposal regarding 'stockholders' right to act by written consent, if properly presented at the meeting. Shareholder proposalAgainstFor
January 22, 2026Intuit Inc.Shareholder proposal requesting the Board to issue a report on the return on investment of the Company's diversity and inclusion programs Shareholder proposalAgainstFor
June 15, 2026HubSpot, Inc.A stockholder proposal to change the Company's Sixth Amended and Restated Bylaws to allow 10% holders of the Company's stock the ability to call a special meeting; and Shareholder proposalForAgainst
June 16, 2026Shopify Inc.Adopt a Policy on Responsible Use of Artificial Intelligence ("AI") in the Company's Business and Operations Shareholder proposalAgainstFor

Search this fund’s votes by company

856 ballot items at 77 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, T. Rowe Price Global Impact Equity Fund (TGBLX) voted at 77 shareholder meetings of 70 companies, on 856 ballot items in all. Where management made a recommendation, the fund followed it on 98.1% of the items and voted against it 15 times. Its most frequent area of disagreement was corporate governance (7 of its votes against management). It voted on 17 shareholder proposals. It voted FOR the board's own proposals less often than T. Rowe Price's funds as a whole (91.6% against 93.7%). It voted differently from most T. Rowe Price funds on 34 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.